Article

Rodi, Maria ORCID: https://orcid.org/0000-0001-6578-0851, de Lastic, Anne-Lise ORCID: https://orcid.org/0000-0002-3152-4777, Panagoulias, Ioannis, Aggeletopoulou, Ioanna ORCID: https://orcid.org/0000-0003-4489-1485, Kelaidonis, Kostas, Matsoukas, John ORCID: https://orcid.org/0000-0001-5554-2964, Apostolopoulos, Vasso ORCID: https://orcid.org/0000-0001-6788-2771 and Mouzaki, Athanasia ORCID: https://orcid.org/0000-0001-5548-7002 (2024) Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis. International Journal of Molecular Sciences, 25 (11). ISSN 1661-6596 (print) 1422-0067 (online)

Matsoukas, John ORCID: https://orcid.org/0000-0001-5554-2964, Deraos, George, Kelaidonis, Kostas, Hossain, Md Kamal, Feehan, Jack ORCID: https://orcid.org/0000-0002-9627-1299, Tzakos, AG ORCID: https://orcid.org/0000-0001-6391-0288, Matsoukas, Elizabeth, Topoglidis, E ORCID: https://orcid.org/0000-0002-0009-9309 and Apostolopoulos, Vasso ORCID: https://orcid.org/0000-0001-6788-2771 (2021) Myelin peptide–mannan conjugate multiple sclerosis vaccines: conjugation efficacy and stability of vaccine ingredient. Vaccines, 9 (12). ISSN 2076-393X